Stock Analysis

Ping An Healthcare and Technology Full Year 2022 Earnings: EPS Beats Expectations, Revenues Lag

Source: Shutterstock

Ping An Healthcare and Technology (HKG:1833) Full Year 2022 Results

Key Financial Results

  • Revenue: CN¥6.16b (down 16% from FY 2021).
  • Net loss: CN¥607.6m (loss narrowed by 61% from FY 2021).
  • CN¥0.56 loss per share (improved from CN¥1.40 loss in FY 2021).
SEHK:1833 Earnings and Revenue Growth March 14th 2023

All figures shown in the chart above are for the trailing 12 month (TTM) period

Ping An Healthcare and Technology EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 3.6%. Earnings per share (EPS) exceeded analyst estimates by 38%.

Looking ahead, revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Online Retail industry in Hong Kong.

Performance of the Hong Kong Online Retail industry.

The company's shares are down 2.4% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on Ping An Healthcare and Technology's balance sheet health.

Valuation is complex, but we're helping make it simple.

Find out whether Ping An Healthcare and Technology is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis